Sabizabulin on "Short Path to FDA EMA", Will "Serve Critical Roles in the US and Abroad" - Veru (VERU) PT Hiked to $36 at Oppenheimer,

Go back to Sabizabulin on "Short Path to FDA EMA", Will "Serve Critical Roles in the US and Abroad" - Veru (VERU) PT Hiked to $36 at Oppenheimer,
(NASDAQ: VERU) Delayed: 2.24 -0.05 (2.18%)
Previous Close $2.29    52 Week High $ 
Open $2.29    52 Week Low $ 
Day High $2.32    P/E N/A 
Day Low $2.22    EPS $ 
Volume 122,592